,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
updated: #asco22: enhertu blows chemotherapy out of the water, redefining breast cancer subgroups along the way endpoints news 
Executive Director. Member NYU @CUPAEthics and NYU PGTME. GE2P2 Independent Bioethics Advisory Committee. MHSc Candidate, UofT.